Pharma.Aero Publishes the White Paper of Corridor 3.0 Hong Kong – Miami Initiative, Building on Pharma.Aero Corridor 2.0 Project
Pharma.Aero has just released the White Paper showcasing the joint, collaborative efforts of Hong Kong International Airport (HKG), Miami International Airport (MIA), and Cathay Cargo, members of Pharma.Aero, seeking to validate the HKG–MIA route specifically for the safe, temperature-controlled transportation of pharmaceutical products, by leveraging the Template Protocol of the previous Pharma.Aero project, Corridor 2.0.
Read here the Pharma.Aero Corridor 3.0 Hong Kong Miami_White Paper
The Corridor 3.0 Hong Kong – Miami is a spin-off initiative building on the achievements of Pharma.Aero projects Corridor 1.0 (2020) and Corridor 2.0 (2021), which validated a foundational framework for airport-to-airport pharma logistics. Corridor 3.0 leverages the proven Template Protocol from Corridor 2.0, outlining critical requirements and performance indicators for end-to-end shipment monitoring, including a comprehensive operational roadmap with route descriptions, transport phases, stakeholder roles, and contingency planning. The template also includes annexes with route qualification guides, data logging procedures, and control point checklists, providing a robust toolset for Pharma.Aero members focused on maintaining high standards for time- and temperature-sensitive cargo.
For Pharma.Aero members only, check the Template Protocol and Annexes in the Member Area of our website.
Are you a Pharma.Aero member, but have not registered yet? Learn how to create a personal account and access the exclusive content for members here.
In 2023, Hong Kong International Airport and Miami International Airport, both CEIV Pharma-certified, and strategic members of Pharma.Aero, partnered with Cathay Cargo, also a CEIV-Pharma certified Pharma.Aero member, to establish a corridor that rigorously adheres to stringent pharmaceutical handling standards.
Corridor 3.0 main objectives:
- validate the route for transport time, and
- validate the route for effectively transporting temperature-sensitive pharmaceutical products within defined transport temperature ranges.
This initiative highlights the tangible, long-term value of Pharma.Aero’s collaborative projects, which are thoughtfully designed with—and for—our members to advance excellence in global healthcare transportation.